-+ 0.00%
-+ 0.00%
-+ 0.00%

ACLARIS THERAPEUTICS INC: EXPECTS TOP LINE DATA FROM BOTH TRIALS IN SECOND HALF OF 2026.

Reuters·01/06/2026 11:59:00

Please log in to view news